FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381054450> ?p ?o ?g. }

• W4381054450 endingPage "352" @default.
• W4381054450 startingPage "345" @default.
• W4381054450 abstract "To compare the performance at 35 + 0 to 36 + 6 weeks' gestation of screening for delivery with pre-eclampsia (PE) at various timepoints, using one of three approaches: placental growth factor (PlGF) concentration, soluble fms-like tyrosine kinase-1 (sFlt-1) to PlGF concentration ratio, or the competing-risks model, which combines maternal risk factors with biomarkers to estimate patient-specific risk.This was a prospective observational study of women attending for a routine hospital visit at 35 + 0 to 36 + 6 weeks' gestation at one of two maternity hospitals in England between 2016 and 2022. During the visit, maternal demographic characteristics and medical history were recorded and serum PlGF, serum sFlt-1 and mean arterial pressure (MAP) were measured. Detection rates (DRs) were evaluated for delivery with PE (defined as per American College of Obstetricians and Gynecologists 2019 criteria) within 1 week, within 2 weeks or at any time after screening, using the following strategies: (i) low PlGF (< 10th percentile); (ii) high sFlt-1/PlGF ratio (> 90th percentile); or (iii) the competing-risks model, in which maternal factors were combined with multiples of the median values of PlGF ('single test'), PlGF and sFlt-1 ('double test') or PlGF, sFlt-1 and MAP ('triple test'). Risk cut-offs corresponded to a screen-positive rate of 10%. DRs were compared between tests.Of 34 782 pregnancies, 831 (2.4%) developed PE. In screening for delivery with PE at any time from assessment, the DR at 10% screen-positive rate was 47% by low PlGF alone, 54% by the single test, 55% by high sFlt-1/PlGF ratio, 61% by the double test and 68% by the triple test. In screening for delivery with PE within 2 weeks from assessment, the respective values were 67%, 74%, 74%, 80% and 87%. In screening for delivery with PE within 1 week from assessment, the respective values were 77%, 81%, 85%, 88% and 91%. For prediction of PE at any time, the DR was significantly higher with the triple test compared to PlGF alone or the sFlt-1/PlGF ratio, with a DR difference (95% CI) of 20.1% (16.7-23.0%) and 12.4% (9.7-15.3%), respectively. Similar results were seen for prediction of PE within 2 weeks (20.6% (14.9-26.8%) and 12.9% (7.7-17.5%), respectively) and prediction of PE within 1 week (13.5% (5.4-21.6%) and 5.4% (0.0-10.8%), respectively). The double test was superior to the sFlt-1/PlGF ratio and the single test was superior to PlGF alone in the prediction of PE within 2 weeks and at any time from assessment, but not within 1 week of assessment.At 35 + 0 to 36 + 6 weeks' gestation, the performance of screening for PE by the competing-risks model triple test is superior to that of PlGF alone or the sFlt-1/PlGF ratio for the development of disease within 1 week, within 2 weeks and at any time from screening. © 2023 International Society of Ultrasound in Obstetrics and Gynecology." @default.
• W4381054450 created "2023-06-18" @default.
• W4381054450 creator A5006680052 @default.
• W4381054450 creator A5006804063 @default.
• W4381054450 creator A5018953701 @default.
• W4381054450 creator A5023475823 @default.
• W4381054450 creator A5055575582 @default.
• W4381054450 creator A5077769927 @default.
• W4381054450 creator A5082209959 @default.
• W4381054450 date "2023-08-30" @default.
• W4381054450 modified "2023-10-18" @default.
• W4381054450 title "Prediction of hypertensive disorders after screening at 36 weeks' gestation: comparison of angiogenic markers with competing‐risks model" @default.
• W4381054450 cites W1979872571 @default.
• W4381054450 cites W2006245385 @default.
• W4381054450 cites W2145917688 @default.
• W4381054450 cites W2179914493 @default.
• W4381054450 cites W2233974801 @default.
• W4381054450 cites W2320399814 @default.
• W4381054450 cites W2730504020 @default.
• W4381054450 cites W2900398263 @default.
• W4381054450 cites W2986009663 @default.
• W4381054450 cites W3020830612 @default.
• W4381054450 cites W3022297674 @default.
• W4381054450 cites W3108569584 @default.
• W4381054450 cites W4233259059 @default.
• W4381054450 cites W4236192354 @default.
• W4381054450 cites W4280491857 @default.
• W4381054450 cites W4297348484 @default.
• W4381054450 cites W4362733558 @default.
• W4381054450 doi "https://doi.org/10.1002/uog.26291" @default.
• W4381054450 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37329494" @default.
• W4381054450 hasPublicationYear "2023" @default.
• W4381054450 type Work @default.
• W4381054450 citedByCount "2" @default.
• W4381054450 countsByYear W43810544502023 @default.
• W4381054450 crossrefType "journal-article" @default.
• W4381054450 hasAuthorship W4381054450A5006680052 @default.
• W4381054450 hasAuthorship W4381054450A5006804063 @default.
• W4381054450 hasAuthorship W4381054450A5018953701 @default.
• W4381054450 hasAuthorship W4381054450A5023475823 @default.
• W4381054450 hasAuthorship W4381054450A5055575582 @default.
• W4381054450 hasAuthorship W4381054450A5077769927 @default.
• W4381054450 hasAuthorship W4381054450A5082209959 @default.
• W4381054450 hasConcept C105795698 @default.
• W4381054450 hasConcept C122048520 @default.
• W4381054450 hasConcept C126322002 @default.
• W4381054450 hasConcept C131872663 @default.
• W4381054450 hasConcept C167734588 @default.
• W4381054450 hasConcept C188816634 @default.
• W4381054450 hasConcept C2776871010 @default.
• W4381054450 hasConcept C2777025900 @default.
• W4381054450 hasConcept C2779184299 @default.
• W4381054450 hasConcept C2779234561 @default.
• W4381054450 hasConcept C29456083 @default.
• W4381054450 hasConcept C33923547 @default.
• W4381054450 hasConcept C46973012 @default.
• W4381054450 hasConcept C54355233 @default.
• W4381054450 hasConcept C71924100 @default.
• W4381054450 hasConcept C86803240 @default.
• W4381054450 hasConceptScore W4381054450C105795698 @default.
• W4381054450 hasConceptScore W4381054450C122048520 @default.
• W4381054450 hasConceptScore W4381054450C126322002 @default.
• W4381054450 hasConceptScore W4381054450C131872663 @default.
• W4381054450 hasConceptScore W4381054450C167734588 @default.
• W4381054450 hasConceptScore W4381054450C188816634 @default.
• W4381054450 hasConceptScore W4381054450C2776871010 @default.
• W4381054450 hasConceptScore W4381054450C2777025900 @default.
• W4381054450 hasConceptScore W4381054450C2779184299 @default.
• W4381054450 hasConceptScore W4381054450C2779234561 @default.
• W4381054450 hasConceptScore W4381054450C29456083 @default.
• W4381054450 hasConceptScore W4381054450C33923547 @default.
• W4381054450 hasConceptScore W4381054450C46973012 @default.
• W4381054450 hasConceptScore W4381054450C54355233 @default.
• W4381054450 hasConceptScore W4381054450C71924100 @default.
• W4381054450 hasConceptScore W4381054450C86803240 @default.
• W4381054450 hasFunder F4320321724 @default.
• W4381054450 hasIssue "3" @default.
• W4381054450 hasLocation W43810544501 @default.
• W4381054450 hasLocation W43810544502 @default.
• W4381054450 hasOpenAccess W4381054450 @default.
• W4381054450 hasPrimaryLocation W43810544501 @default.
• W4381054450 hasRelatedWork W2004453285 @default.
• W4381054450 hasRelatedWork W2082179663 @default.
• W4381054450 hasRelatedWork W2147889289 @default.
• W4381054450 hasRelatedWork W2153454827 @default.
• W4381054450 hasRelatedWork W2321355694 @default.
• W4381054450 hasRelatedWork W2911558734 @default.
• W4381054450 hasRelatedWork W4281694272 @default.
• W4381054450 hasRelatedWork W4381054450 @default.
• W4381054450 hasRelatedWork W985205842 @default.
• W4381054450 hasRelatedWork W2184760075 @default.
• W4381054450 hasVolume "62" @default.
• W4381054450 isParatext "false" @default.
• W4381054450 isRetracted "false" @default.
• W4381054450 workType "article" @default.